ALGN vs DAWN · P/E 35, rev $2.10B vs rev $131.2M
Align Technology Inc (ALGN) versus Day One Biopharmaceuticals Inc (DAWN) — a side-by-side from cached financials, not a winner call.
Align Technology Inc (ALGN) is a medical instruments & supplies company listed on US.
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
Latest reported ALGN revenue for 2026-06-30 was $2.10B. Net income was $221.1M. ALGN currently screens at market cap $14.17B and trailing P/E 35.2.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
ALGN currently screens at market cap $14.17B and trailing P/E 35.2. DAWN currently screens at market cap $656.8M.
Not investment advice. Open the ALGN and DAWN stock pages for the full models.
Not investment advice.